Cargando…

Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting

SIMPLE SUMMARY: Well-differentiated/dedifferentiated liposarcomas (WDLPS/DDLPS) are the most frequent soft tissue sarcomas. Despite the hopes raised by some targeted therapies, effective well-tolerated treatments for DDLPS are still lacking. Small-molecule FGFR inhibitors are currently evaluated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dadone-Montaudié, Bérengère, Laroche-Clary, Audrey, Mongis, Aline, Chamorey, Emmanuel, Di Mauro, Ilaria, Chaire, Vanessa, Finetti, Pascal, Schiappa, Renaud, Le Loarer, François, Birtwisle-Peyrottes, Isabelle, Michiels, Jean-François, Bertucci, François, Pedeutour, Florence, Italiano, Antoine, Bianchini, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589658/ https://www.ncbi.nlm.nih.gov/pubmed/33092134 http://dx.doi.org/10.3390/cancers12103058

Ejemplares similares

Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
por: Laroche-Clary, Audrey, et al.
Publicado: (2017)

MDM2 antagonists synergize with PI3K/mTOR inhibition in well-differentiated/dedifferentiated liposarcomas
por: Laroche, Audrey, et al.
Publicado: (2017)

MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction
por: Di Mauro, Ilaria, et al.
Publicado: (2020)

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies
por: Toulmonde, Maud, et al.
Publicado: (2020)

MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies
por: Roy, Shomereeta, et al.
Publicado: (2020)

Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition
por: Fourneaux, Benjamin, et al.
Publicado: (2019)

Expression of Concern to: Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition
por: Fourneaux, Benjamin, et al.
Publicado: (2019)

Superficial CD34-positive Fibroblastic Tumour: Unique Subungual Presentation with Confounding Clinical Findings Resembling Fibrokeratoma-like Bowen’s Disease
por: PERRIN, Christophe, et al.
Publicado: (2021)

ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status
por: Laroche-Clary, Audrey, et al.
Publicado: (2020)

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
por: Traweek, Raymond S., et al.
Publicado: (2022)

Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report
por: Grifasi, Carlo, et al.
Publicado: (2013)

Cracking the riddle of dedifferentiated liposarcoma: is EV-MDM2 a key?
por: Casadei, Lucia, et al.
Publicado: (2020)

Prognostic impact of circulating tumor cells in patients with soft‐tissue sarcomas: a prospective study
por: Blanchi, Julie, et al.
Publicado: (2023)

MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models
por: Patt, Andrew, et al.
Publicado: (2020)

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
por: Laroche, Audrey, et al.
Publicado: (2017)

Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study
por: Spalato-Ceruso, Mariella, et al.
Publicado: (2022)

Challenging dedifferentiated liposarcoma identified by MDM2-amplification, a report of two cases
por: Lokka, Suvi, et al.
Publicado: (2014)

Hypopharyngeal Dedifferentiated Liposarcoma in the MDM2 Era: A Case Report and Short Review
por: Wanes, Peter, et al.
Publicado: (2020)

Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous dedifferentiation
por: Nguyen, Vinh N., et al.
Publicado: (2015)

Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH
por: Al-Maghraby, Hatem Q., et al.
Publicado: (2010)

AGAP3 : A novel BRAF fusion partner in pediatric pancreatic‐type acinar cell carcinoma
por: Paoli, Charlotte, et al.
Publicado: (2022)

Rare Aggressive Behavior of MDM2-Amplified Retroperitoneal Dedifferentiated Liposarcoma, with Brain, Lung and Subcutaneous Metastases
por: Ben Salha, Imen, et al.
Publicado: (2016)

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma
por: Seligson, Nathan D., et al.
Publicado: (2019)

BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
por: Laroche-Clary, A, et al.
Publicado: (2015)

Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma
por: Przybyl, Joanna, et al.
Publicado: (2022)

Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
por: Dorian Yarih, Garcia-Ortega, et al.
Publicado: (2021)

Dedifferentiated liposarcoma of the retroperitoneum with osteosarcomatous component
por: Sun, Wenbin, et al.
Publicado: (2012)

Dedifferentiated Paratesticular Liposarcoma with Osseous Metaplasia
por: Chondros, Kostas, et al.
Publicado: (2015)

Dedifferentiated liposarcoma of the adult male breast
por: Raj, Sean D., et al.
Publicado: (2015)

Scattered genomic amplification in dedifferentiated liposarcoma
por: Mandahl, Nils, et al.
Publicado: (2017)

Multifocal Dedifferentiated Liposarcoma of the Jejunal Mesentery
por: Khanduri, Archana, et al.
Publicado: (2021)

Giant Retroperitoneal Mucinous Tumor Supportively Diagnosed as a Dedifferentiated Liposarcoma by Fluorescence In Situ Hybridization of MDM2 Gene
por: Naiki, Taku, et al.
Publicado: (2011)

PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53
por: Grellety, Thomas, et al.
Publicado: (2015)

Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications
por: Fourneaux, Benjamin, et al.
Publicado: (2016)

Very Late Local Relapse of Ewing's Sarcoma of the Head and Neck treated with Aggressive Multimodal Therapy
por: Thariat, J., et al.
Publicado: (2008)

An unusual case of primary colonic dedifferentiated liposarcoma()
por: Türkoğlu, Mehmet Akif, et al.
Publicado: (2013)

Dedifferentiated Liposarcoma Occurring in the Right Pulmonary Hilum
por: Koike, Hirofumi, et al.
Publicado: (2017)

A case of dedifferentiated liposarcoma of the heart and stomach
por: Hisata, Yoichi, et al.
Publicado: (2017)

Dedifferentiated liposarcoma of the gallbladder: first reported case
por: da Costa, Adriano Carneiro, et al.
Publicado: (2018)

Adipogenesis induces growth inhibition of dedifferentiated liposarcoma
por: Kim, Yu Jin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9u49f61tvjvom23jn61gdcnnrp